| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A case-control study on breast cancer and body mass
|
Taioli, E.
|
|
1995
|
31 |
5 |
p. 723-728
6 p.
|
artikel
|
| 2 |
Adoptive transfer of ex vivo activated memory T-cells with or without cyclophosphamide for advanced metastatic melanoma: Results in 36 patients
|
Gold, J.E.
|
|
1995
|
31 |
5 |
p. 698-708
11 p.
|
artikel
|
| 3 |
A double-blind comparison study of tropisetron and placebo in the prevention of radiation-induced diarrhoea
|
Kardamakis, D.
|
|
1995
|
31 |
5 |
p. 850-
1 p.
|
artikel
|
| 4 |
Biological response modifiers
|
Zwierzina, H.
|
|
1995
|
31 |
5 |
p. 815-816
2 p.
|
artikel
|
| 5 |
Biological response to intrahepatic adoptive immunotherapy with autologous interferon activated macrophages
|
Hennemann, B.
|
|
1995
|
31 |
5 |
p. 852-
1 p.
|
artikel
|
| 6 |
Biology and therapy of Hodgkin's Disease
|
Wolf, J.
|
|
1995
|
31 |
5 |
p. 830-831
2 p.
|
artikel
|
| 7 |
Breast cancer angiogenesis: Therapy target and prognostic factor
|
Harris, A.L.
|
|
1995
|
31 |
5 |
p. 831-832
2 p.
|
artikel
|
| 8 |
Chemotherapy in head and neck cancer
|
Armand, J.P.
|
|
1995
|
31 |
5 |
p. 819-822
4 p.
|
artikel
|
| 9 |
Childhood cancer: Trends in incidence, survival and mortality
|
Draper, G.J.
|
|
1995
|
31 |
5 |
p. 653-654
2 p.
|
artikel
|
| 10 |
Coenzymes Q9 and Q10 in skeletal and cardiac muscle in tumour-bearing exercising rats
|
Daneryd, P.
|
|
1995
|
31 |
5 |
p. 760-765
6 p.
|
artikel
|
| 11 |
Combined modality treatment in small cell lung cancer (SCLC)
|
Gregor, A.
|
|
1995
|
31 |
5 |
p. 816-818
3 p.
|
artikel
|
| 12 |
Comparison of continuous infusion and bolus administration of ifosfamide in children
|
Boddy, A.V.
|
|
1995
|
31 |
5 |
p. 785-790
6 p.
|
artikel
|
| 13 |
Conformai radiation treatment: a critical appraisal
|
Ling, C.C.
|
|
1995
|
31 |
5 |
p. 799-803
5 p.
|
artikel
|
| 14 |
Controversies in testicular cancer management
|
Horwich, A.
|
|
1995
|
31 |
5 |
p. 840-841
2 p.
|
artikel
|
| 15 |
Cutaneous T-cell lymphoma: Molecular genetics, immunology and pathogenesis
|
Reinhold, U.
|
|
1995
|
31 |
5 |
p. 793-799
7 p.
|
artikel
|
| 16 |
Decision making in abdominal surgery following chemotherapy for testicular cancer
|
Hendry, W.F.
|
|
1995
|
31 |
5 |
p. 649-650
2 p.
|
artikel
|
| 17 |
Detection of TP53 gene mutations in human sarcomas
|
Castresana, J.S.
|
|
1995
|
31 |
5 |
p. 735-738
4 p.
|
artikel
|
| 18 |
Determination of oestrogen receptor by enzyme immunoassay
|
Hyder, S.M.
|
|
1995
|
31 |
5 |
p. 852-853
2 p.
|
artikel
|
| 19 |
Developments in radiotherapy
|
Rampling, R.
|
|
1995
|
31 |
5 |
p. 836-837
2 p.
|
artikel
|
| 20 |
Differences in the growth pattern and clinical course of EBV-LMP1 expressing and non-expressing nasopharyngeal carcinomas
|
Hu, Li-Fu
|
|
1995
|
31 |
5 |
p. 658-660
3 p.
|
artikel
|
| 21 |
Exceptional toxicity of 5-fluorouracil and interferon-α in a patient with hepatocellular carcinoma
|
Salminen, E.
|
|
1995
|
31 |
5 |
p. 849-
1 p.
|
artikel
|
| 22 |
Feasibility of five courses of pre-operative chemotherapy in patients with resectable adenocarcinoma of the oesophagus or gastrooesophageal junction
|
Ajani, J.A.
|
|
1995
|
31 |
5 |
p. 665-670
6 p.
|
artikel
|
| 23 |
Flow cytometric and cytophotometric DNA analysis cannot predict subsequent tumour recurrence in pathological stage IIA/B non-seminomatous testicular germ cell tumour patients who do not receive adjuvant chemotherapy
|
Albers, P.
|
|
1995
|
31 |
5 |
p. 848-849
2 p.
|
artikel
|
| 24 |
Gene therapy for cancer
|
Gore, M.
|
|
1995
|
31 |
5 |
p. 805-806
2 p.
|
artikel
|
| 25 |
Genetic testing of the common cancers: Potential and problems
|
Ponder, B.A.J.
|
|
1995
|
31 |
5 |
p. 807-808
2 p.
|
artikel
|
| 26 |
Haemopoietic growth factors: Uses and misuses
|
Bronchud, M.H.
|
|
1995
|
31 |
5 |
p. 813-814
2 p.
|
artikel
|
| 27 |
High-dose carboplatin and etoposide for salvage chemotherapy of germ cell tumours
|
Lampe, H.
|
|
1995
|
31 |
5 |
p. 717-723
7 p.
|
artikel
|
| 28 |
High-dose chemotherapy in tumours other than lymphomas and breast cancer
|
Droz, J.P.
|
|
1995
|
31 |
5 |
p. 811-812
2 p.
|
artikel
|
| 29 |
High-dose chemotherapy of breast cancer: Current status and developmental strategies
|
Crown, J.
|
|
1995
|
31 |
5 |
p. 809-811
3 p.
|
artikel
|
| 30 |
High dose therapy and ABMT rescue in lymphoma and solid tumours
|
Philip, T.
|
|
1995
|
31 |
5 |
p. 808-809
2 p.
|
artikel
|
| 31 |
Influence of molecular weight on passive tumour accumulation of a soluble macromolecular drug carrier
|
Seymour, L.W.
|
|
1995
|
31 |
5 |
p. 766-770
5 p.
|
artikel
|
| 32 |
Is There a need to follow-up cancer patients?
|
Brada, M.
|
|
1995
|
31 |
5 |
p. 655-657
3 p.
|
artikel
|
| 33 |
Kinetics of prostate-specific antigen after manipulation of the prostate
|
Bossens, M.M.F.
|
|
1995
|
31 |
5 |
p. 682-685
4 p.
|
artikel
|
| 34 |
Medical management of non-small cell lung cancer
|
Smith, I.E.
|
|
1995
|
31 |
5 |
p. 818-819
2 p.
|
artikel
|
| 35 |
Molecular basis of radioresistance
|
Coucke, P.A.
|
|
1995
|
31 |
5 |
p. 844-846
3 p.
|
artikel
|
| 36 |
Mutational analysis of the MCC gene by single-strand conformational polymorphism analysis
|
Cripps, K.J.
|
|
1995
|
31 |
5 |
p. 853-855
3 p.
|
artikel
|
| 37 |
Neurotoxicity is not enhanced by increased dose intensities of cisplatin administration
|
Hilkens, P.H.E.
|
|
1995
|
31 |
5 |
p. 678-681
4 p.
|
artikel
|
| 38 |
New editor-in-chief for the european journal of cancer professor Hans-Jörg Senn
|
Peckham, Michael
|
|
1995
|
31 |
5 |
p. 647-
1 p.
|
artikel
|
| 39 |
New endocrine agents in the treatment of breast cancer
|
Mouridsen, H.T.
|
|
1995
|
31 |
5 |
p. 826-827
2 p.
|
artikel
|
| 40 |
News
|
|
|
1995
|
31 |
5 |
p. 846-
1 p.
|
artikel
|
| 41 |
Ovarian cancer: Diagnostic second laparotomy and salvage intra-peritoneal chemotherapy fail again
|
Vogl, S.E.
|
|
1995
|
31 |
5 |
p. 651-653
3 p.
|
artikel
|
| 42 |
Ovarian cancer—New insights into systemic therapy
|
Neijt, J.P.
|
|
1995
|
31 |
5 |
p. 823-824
2 p.
|
artikel
|
| 43 |
Patterns of childhood cancer mortality: America, Asia and Oceania
|
Levi, F.
|
|
1995
|
31 |
5 |
p. 771-782
12 p.
|
artikel
|
| 44 |
Phase II study of intraperitoneal cisplatin plus systemic etoposide as second-line treatment in patients with small volume residual ovarian cancer
|
de Jong, R.S.
|
|
1995
|
31 |
5 |
p. 709-713
5 p.
|
artikel
|
| 45 |
Phase II study of rapid-scheduled etoposide in paediatric soft tissue sarcomas
|
Phillips, M.B.
|
|
1995
|
31 |
5 |
p. 782-784
3 p.
|
artikel
|
| 46 |
Professor Michael Peckham retires as editor-in-chief of the European Journal of Cancer
|
Veronesi, Umberto
|
|
1995
|
31 |
5 |
p. I-
1 p.
|
artikel
|
| 47 |
Prognostic factors for survival after breast conserving therapy for stage I and II breast cancer. The role of local recurrence
|
Kemperman, H.
|
|
1995
|
31 |
5 |
p. 690-698
9 p.
|
artikel
|
| 48 |
Prognostic significance of TGF-β2 expression in female breast cancer
|
Auvinen, P.
|
|
1995
|
31 |
5 |
p. 851-
1 p.
|
artikel
|
| 49 |
Prognostic value of total cathepsin B in invasive ductal carcinoma of the breast
|
Budihna, M.
|
|
1995
|
31 |
5 |
p. 661-664
4 p.
|
artikel
|
| 50 |
Programmed cell death in response to chemotherapeutic agents in human germ cell tumour lines
|
Huddart, R.A.
|
|
1995
|
31 |
5 |
p. 739-746
8 p.
|
artikel
|
| 51 |
Prostate cancer: a continuum of controversy
|
Denis, L.J.
|
|
1995
|
31 |
5 |
p. 839-840
2 p.
|
artikel
|
| 52 |
Quality assurance in cervical cancer screening: The Icelandic experience 1964–1993
|
Sigurdsson, K.
|
|
1995
|
31 |
5 |
p. 728-734
7 p.
|
artikel
|
| 53 |
Recent advances in the management of lymphoma
|
Cavalli, F.
|
|
1995
|
31 |
5 |
p. 841-844
4 p.
|
artikel
|
| 54 |
Recent developments in the biology and management of advanced bladder cancer
|
van Oosterom, A.T.
|
|
1995
|
31 |
5 |
p. 838-839
2 p.
|
artikel
|
| 55 |
Relationship between cathepsin D and other pathological and biological parameters in 1752 patients with primary breast cancer
|
Gion, M.
|
|
1995
|
31 |
5 |
p. 671-677
7 p.
|
artikel
|
| 56 |
Retinoids in oncology
|
Aapro, M.S.
|
|
1995
|
31 |
5 |
p. 834-835
2 p.
|
artikel
|
| 57 |
Signal transduction inhibitors
|
Grunicke, H.
|
|
1995
|
31 |
5 |
p. 833-834
2 p.
|
artikel
|
| 58 |
Single-dose intraperitoneal radioimmunotherapy with the murine monoclonal antibody I-131 MOv18: Clinical results in patients with minimal residual disease of ovarian cancer
|
Crippa, F.
|
|
1995
|
31 |
5 |
p. 686-690
5 p.
|
artikel
|
| 59 |
Taxoids
|
Kaye, S.B.
|
|
1995
|
31 |
5 |
p. 824-826
3 p.
|
artikel
|
| 60 |
Temozolomide reduces the metastatic potential of lewis lung carcinoma (3LL) in mice: Role of α-6 integrin phosphorylation
|
Tentori, L.
|
|
1995
|
31 |
5 |
p. 746-754
9 p.
|
artikel
|
| 61 |
The effect of different routes of administration of 5-fluorouracil on thymidylate synthase inhibition in the rat
|
Van Der Wilt, C.L.
|
|
1995
|
31 |
5 |
p. 754-760
7 p.
|
artikel
|
| 62 |
The effects of oral pentoxifylline on interleukin-2 toxicity in patients with metastatic renal cell carcinoma
|
Anderson, J.A.
|
|
1995
|
31 |
5 |
p. 714-717
4 p.
|
artikel
|
| 63 |
The present role of laparoscopy in gynaecological oncology; the EORTC point of view
|
Trimbos, J.B.
|
|
1995
|
31 |
5 |
p. 803-805
3 p.
|
artikel
|
| 64 |
Therapy of carcinoma of the oesophagus: Either attempt it not or succeed
|
Ajani, J.A.
|
|
1995
|
31 |
5 |
p. 790-793
4 p.
|
artikel
|
| 65 |
Topoisomerase I inhibitors and other new cytotoxic drugs
|
Verweij, J.
|
|
1995
|
31 |
5 |
p. 828-830
3 p.
|
artikel
|
Tijdschrift beschrijving